192 related articles for article (PubMed ID: 8266069)
21. Mucosal immunity, HIV transmission, and AIDS.
Miller CJ; McGhee JR; Gardner MB
Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
[No Abstract] [Full Text] [Related]
22. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
23. Changing paradigms for an HIV vaccine.
Schultz AM
Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
[No Abstract] [Full Text] [Related]
24. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
25. HIV vaccines--where are we going?
Heilman CA; Baltimore D
Nat Med; 1998 May; 4(5 Suppl):532-4. PubMed ID: 9585205
[No Abstract] [Full Text] [Related]
26. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
28. Primate models of AIDS vaccine development.
Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
[No Abstract] [Full Text] [Related]
29. [Pathogenicity of human immunodeficiency virus (HIV)].
Kurimura K
Uirusu; 1991 Dec; 41(2):77-84. PubMed ID: 1810087
[No Abstract] [Full Text] [Related]
30. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO
Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
[No Abstract] [Full Text] [Related]
31. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
Geretti AM; Hulskotte E; Osterhaus AD
J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
[No Abstract] [Full Text] [Related]
32. Progress towards a vaccine to prevent sexual transmission of HIV.
Miller CJ; McGhee JR
Nat Med; 1996 Jul; 2(7):751-2. PubMed ID: 8673919
[No Abstract] [Full Text] [Related]
33. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
34. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
35. [Live attenuated viruses: a new strategy for vaccination against AIDS].
Molina JM
Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
[No Abstract] [Full Text] [Related]
36. CD8(+) T cells in preventing HIV infection and disease.
McDermott AB; Koup RA
AIDS; 2012 Jun; 26(10):1281-92. PubMed ID: 22441256
[TBL] [Abstract][Full Text] [Related]
37. [Brief history of AIDS in non-human primates and its contribution to the study of acquired immunodeficiency syndrome].
Málaga CA; Kraiselburd E; Lavergne JA; Del Llano AM; Amieiro JP
P R Health Sci J; 1993 Apr; 12(1):47-54. PubMed ID: 8511246
[TBL] [Abstract][Full Text] [Related]
38. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination.
Baig J; Levy DB; McKay PF; Schmitz JE; Santra S; Subbramanian RA; Kuroda MJ; Lifton MA; Gorgone DA; Wyatt LS; Moss B; Huang Y; Chakrabarti BK; Xu L; Kong WP; Yang ZY; Mascola JR; Nabel GJ; Carville A; Lackner AA; Veazey RS; Letvin NL
J Virol; 2002 Nov; 76(22):11484-90. PubMed ID: 12388710
[TBL] [Abstract][Full Text] [Related]
39. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
40. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]